Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$20.45 - $26.49 $807,775 - $1.05 Million
39,500 Added 223.69%
57,158 $1.24 Million
Q4 2023

Feb 14, 2024

SELL
$19.02 - $30.13 $81,500 - $129,107
-4,285 Reduced 19.53%
17,658 $392,000
Q3 2023

Nov 14, 2023

BUY
$30.46 - $46.04 $414,956 - $627,202
13,623 Added 163.74%
21,943 $668,000
Q2 2023

Aug 14, 2023

BUY
$31.57 - $37.73 $262,662 - $313,913
8,320 New
8,320 $310,000
Q1 2022

May 16, 2022

SELL
$34.38 - $65.77 $532,374 - $1.02 Million
-15,485 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$63.78 - $97.86 $987,633 - $1.52 Million
15,485 New
15,485 $1.09 Million

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.45B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.